You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SUVN-502

Showing 1 - 25 of 28
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Agitation, Alzheimer's Type Dementia Trial in Costa Mesa, Miami (Masupirdine 50 mg, Masupirdine 100 mg, Placebo)

Recruiting
  • Agitation
  • Alzheimer's Type Dementia
  • Masupirdine 50 mg
  • +2 more
  • Costa Mesa, California
  • +1 more
May 30, 2022

Alzheimer, Dementia, Cognition Disorders Trial (SUVN-502)

No longer available
  • Alzheimer Disease
  • +2 more
  • SUVN-502
  • (no location specified)
Sep 25, 2020

Alzheimer's Disease Trial in United States (SUVN-502, Placebo, Donepezil)

Completed
  • Alzheimer's Disease
  • SUVN-502
  • +3 more
  • Phoenix, Arizona
  • +70 more
Nov 20, 2020

NHL, Relapsed, Adult, B-cell Lymphoma, B-cell Leukemia Trial (KUR-502)

Not yet recruiting
  • NHL, Relapsed, Adult
  • +3 more
  • KUR-502
  • (no location specified)
Aug 2, 2022

Narcolepsy Trial in Canada, United States (SUVN-G3031, Placebo)

Recruiting
  • Narcolepsy
  • Birmingham, Alabama
  • +40 more
Sep 9, 2022

CLN3, Batten Disease Trial in Columbus (AT-GTX-502)

Active, not recruiting
  • CLN3
  • Batten Disease
  • AT-GTX-502
  • Columbus, Ohio
    Nationwide Children's Hospital
Jul 18, 2022

Mobility Limitation Trial in Pittsburgh (On the Move group exercise)

Recruiting
  • Mobility Limitation
  • On the Move group exercise
  • Pittsburgh, Pennsylvania
    University of Pittsburgh
Jul 6, 2022

Non-Alcoholic Fatty Liver Disease Trial in Porto (BAR502, Placebo)

Not yet recruiting
  • Non-Alcoholic Fatty Liver Disease
  • Porto, Portugal
    BlueClinical Phase I
Jan 5, 2022

Blepharitis Trial in United States (ISV-502 (1.0% azithromycin and 0.1% dexamethasone combined), Azasite, Dexamethasone)

Completed
  • Blepharitis
  • ISV-502 (1.0% azithromycin and 0.1% dexamethasone combined)
  • +3 more
  • Chandler, Arizona
  • +44 more
Nov 18, 2021

Duchenne Muscular Dystrophy Trial in Chicago, Richmond, Calgary (Viltolarsen)

Enrolling by invitation
  • Duchenne Muscular Dystrophy
  • Chicago, Illinois
  • +2 more
Nov 12, 2021

Anesthesia Trial in New Delhi (Propofol)

Not yet recruiting
  • Anesthesia
  • New Delhi, Delhi, India
    Nitin Sethi
Jul 29, 2023

Alopecia Areata, Alopecia Universalis, Alopecia Totalis Trial in United States (ATI 502 0.46% Topical Solution)

Terminated
Has Results
  • Alopecia Areata
  • +2 more
  • ATI 502 0.46% Topical Solution
  • Rogers, Arkansas
  • +19 more
Sep 17, 2020

Breast Cancer, Non Small Cell Lung Cancer, GastroEsophageal Cancer Trial in Belgium, United States (ADCT-502)

Terminated
Has Results
  • Breast Cancer
  • +3 more
  • Palo Alto, California
  • +4 more
Jan 6, 2021

Healthy Trial in Madison (ARRY-502, Placebo)

Completed
  • Healthy
  • Madison, Wisconsin
    (unnamed)
Sep 30, 2020

Atopic Dermatitis Trial in United States (ATI-502)

Completed
Has Results
  • Atopic Dermatitis
  • Encinitas, California
  • +5 more
Feb 5, 2020

Portal Hypertension in Compensated Advanced Chronic Liver

Recruiting
  • Advanced Chronic Liver Disease, NASH
  • VCTE with splenic stiffness measurement
  • Indianapolis, Indiana
    Indiana University School of Medicine
Jan 13, 2021

Mucopolysaccharidosis IVA (Morquio A Syndrome) Trial in Australia (BMN 110)

Completed
  • Mucopolysaccharidosis IVA (Morquio A Syndrome)
  • BMN 110
  • Westmead, New South Wales, Australia
  • +4 more
Sep 24, 2019

MDD Trial in Kansas City (SUVN-911)

Completed
  • Major Depressive Disorder
  • Kansas City, Kansas
    IQVIA Phase One Services, LLC
Aug 8, 2018

Non-interventional Substudy of ALX-HPP-502 to Assess Natural

Completed
Has Results
  • Hypophosphatasia
  • Bone Disease
  • Retrospective Case Only
  • Saint Louis, Missouri
    (unnamed)
Mar 11, 2019

Depressive Disorder, Major Trial in Kansas City (SUVN-911, Placebo)

Completed
  • Depressive Disorder, Major
  • Kansas City, Kansas
    QuintilesIMS Phase 1 Services, LLC
May 25, 2018

Cognitive Disorder Trial in Lenexa (SUVN-D4010)

Completed
  • Cognitive Disorder
  • Lenexa, Kansas
    PRA Health Sciences
Sep 21, 2017

Cognitive Disorders Trial in Overland Park (SUVN-G3031)

Completed
  • Cognitive Disorders
  • Overland Park, Kansas
    Quintiles
Sep 21, 2017

Cognitive Disorders Trial in Overland Park (SUVN-G3031, Placebo)

Completed
  • Cognitive Disorders
  • Overland Park, Kansas
    Quintiles
Oct 13, 2016

Cognitive Disorders Trial in Lenexa (SUVN-D4010, Placebo)

Completed
  • Cognitive Disorders
  • Lenexa, Kansas
    PRA Health Sciences
Jun 3, 2016

Vision Impairment, Hearing Impairment, Obesity Trial in Brisbane (Health Intervention Package)

Completed
  • Vision Impairment
  • +2 more
  • Health Intervention Package
  • Brisbane, Queensland, Australia
    Queensland Centre for Intellectual and Developmental Disability,
Jan 11, 2017